Global Pharmaceutical One-Material Blisters (OMB) Supply, Demand and Key Producers, 2026-2032
The global Pharmaceutical One-Material Blisters (OMB) market size is expected to reach $ 848 million by 2032, rising at a market growth of 8.3% CAGR during the forecast period (2026-2032).
Pharmaceutical One-Material Blisters (OMB) are unit-dose pharmaceutical packaging systems in which the blister-forming web and compatible lidding material are primarily made from the same polymer or are designed to enter the same material recycling stream. These blisters are mainly used for tablets, hard capsules, softgel capsules, lozenges, and other solid dosage forms, with cavities typically produced by thermoforming and sealed using push-through, peelable, or peel-push lidding materials. Commercial OMB structures are primarily based on PET, PP, PE, and, for higher-barrier applications, COC. In addition to improving recyclability and reducing dependence on conventional multi-material structures such as PVC–aluminum and cold-form aluminum blisters, pharmaceutical OMB solutions must meet strict requirements for moisture and oxygen barrier performance, seal integrity, drug compatibility, mechanical strength, machinability, patient accessibility, shelf-life protection, and regulatory compliance.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical One-Material Blisters (OMB) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical One-Material Blisters (OMB) that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical One-Material Blisters (OMB) market
2. What is the demand of the global Pharmaceutical One-Material Blisters (OMB) market?
3. What is the year over year growth of the global Pharmaceutical One-Material Blisters (OMB) market?
4. What is the production and production value of the global Pharmaceutical One-Material Blisters (OMB) market?
5. Who are the key producers in the global Pharmaceutical One-Material Blisters (OMB) market?
6. What are the growth factors driving the market demand?
Pharmaceutical One-Material Blisters (OMB) are unit-dose pharmaceutical packaging systems in which the blister-forming web and compatible lidding material are primarily made from the same polymer or are designed to enter the same material recycling stream. These blisters are mainly used for tablets, hard capsules, softgel capsules, lozenges, and other solid dosage forms, with cavities typically produced by thermoforming and sealed using push-through, peelable, or peel-push lidding materials. Commercial OMB structures are primarily based on PET, PP, PE, and, for higher-barrier applications, COC. In addition to improving recyclability and reducing dependence on conventional multi-material structures such as PVC–aluminum and cold-form aluminum blisters, pharmaceutical OMB solutions must meet strict requirements for moisture and oxygen barrier performance, seal integrity, drug compatibility, mechanical strength, machinability, patient accessibility, shelf-life protection, and regulatory compliance.
Key Findings
- Global shipment volume reached approximately 36,154 MT in 2025
- Average global selling price reached US$13 per kg in 2025
- PET remains the broadest commercially available material platform
- Tablets and hard capsules dominate pharmaceutical blister demand
- Europe leads regulatory driven qualification and early commercialization
- Supplier partnerships remain central to complete system commercialization
Market Trends
The market is shifting from conventional PVC–aluminum and multilayer barrier structures toward PET, PP and other polymer systems engineered for a single recycling stream. Product development is increasingly focused on transparent polymer lidding, improved push-through performance, wider forming and sealing windows, uniform residual wall thickness after thermoforming and compatibility with existing high-speed packaging equipment. PET has developed the broadest commercial partnership network: Huhtamaki’s mono-PET Push Tab lidding is paired with Klöckner Pentaplast’s kpNext R1 forming web, while PAXXUS supplies an alternative all-polyester pharmaceutical lid for the same forming-film platform. PP is gaining strategic importance because its moisture barrier is inherent to the polymer and can be retained across the thermoformed cavity wall; SÜDPACK, Liveo Research and TekniPlex have each developed PP or PP-stream-compatible systems. PE remains a more concentrated route represented by Amcor’s AmSky family, while COC supports medium-to-high barrier applications. The long-term direction is toward validated total-pack systems, third-party recyclability certification, lower material weight, aluminum and PVC reduction, mass-balance or recycled-content options and closer collaboration among resin producers, film converters, lidding suppliers, machinery companies and pharmaceutical customers.Market Dynamics
Drivers
Sustainability commitments by pharmaceutical companies and evolving packaging policy are the principal market drivers. Regulation (EU) 2025/40 introduces lifecycle requirements covering packaging sustainability, minimization, labelling and waste management, creating a strong design signal for recyclable packaging even where pharmaceutical immediate packaging receives differentiated treatment to protect medicine quality and security of supply. At the customer level, OMB allows drug owners to reduce PVC and aluminum consumption, improve packaging carbon profiles and demonstrate progress toward circular-packaging objectives. Adoption is also supported by solutions that can run on existing blister lines without significant tooling changes or speed reductions, reducing the capital required for qualification. The commercialization of complete bottom-web and lidding combinations further lowers technical risk, while successful deployment in branded OTC products demonstrates that mono-material systems can move beyond laboratory trials into large-scale pharmaceutical use.Restraints
The principal restraint is the technical and regulatory burden associated with replacing a validated primary pharmaceutical package. Standard PET structures generally provide lower moisture protection than PP, COC, PVdC-coated films or cold-form aluminum, limiting immediate conversion for highly hygroscopic drugs. Higher barrier performance can require specialty polymers, barrier layers or modified sealing systems, increasing material cost and complicating recycling claims. Each packaging change may require drug–package compatibility testing, seal-integrity verification, transportation testing, accelerated and long-term stability studies, equipment trials and regulatory documentation. India’s Drugs Rules require pharmaceutical packaging materials to comply with defined specifications and to be compatible with the drugs they contain, while China’s NMPA associated-review framework requires drug-packaging-material information and relevant changes to be maintained and evaluated with the finished medicine. Long validation cycles, conservative risk management and the possibility of requalification across multiple countries therefore slow conversion of established products.Opportunities
The most attractive opportunity is the development of higher-barrier PP and COC systems capable of replacing selected PVC–PVdC, PVC–PCTFE and cold-form aluminum applications while remaining compatible with conventional form-fill-seal equipment. Additional opportunities include transparent aluminum-free packs, child-resistant and senior-friendly opening structures, thinner forming webs, printable polymer lids and systems incorporating chemically recycled or mass-balance resin. Export-oriented pharmaceutical manufacturers in India and China represent an important qualification pool because packaging for European and North American markets is increasingly assessed against sustainability and material-efficiency criteria. OTC medicines, generic tablets, vitamins and dietary supplements offer earlier conversion potential because many products have moderate barrier requirements and faster packaging-development cycles. Japan also presents an emerging development opportunity: KANAe has introduced a development-stage polyolefin PTP system evaluated for the PP recycling stream and designed for use on an existing packaging machine, indicating scope for localized material-and-machinery co-development.Challenges
Manufacturers must balance recyclability with pharmaceutical safety, shelf-life protection and patient usability. A package described as one-material may still contain inks, coatings, sealants or functional layers that affect its acceptance in a specific recycling system. Collection and sorting infrastructure also varies significantly by country, meaning that technical recyclability does not automatically result in recycling at scale. Thermoforming redistributes film thickness, so barrier performance at the thinnest cavity areas must remain consistent across production speeds, tooling geometries and material batches. Lidding films must deliver reliable sealing while maintaining controlled push-through or peel forces, print quality and resistance to transport damage. Commercial risks include resin-price volatility, low early-stage production volumes, extended customer testing, uncertain pharmaceutical change timelines and the possibility that existing PVC or aluminum structures remain economically preferable for high-barrier products. Suppliers therefore need robust application laboratories, machine-testing capabilities, pharmaceutical quality systems and long-term technical support rather than relying solely on an environmental value proposition.Industry Chain Analysis
The upstream industry comprises pharmaceutical-grade PET, PP, PE and COC resins, functional additives, heat-seal materials, barrier technologies, printing inks, coating chemicals and extrusion or thermoforming equipment. Midstream companies manufacture rigid forming webs, flexible or semi-rigid lidding films and complete matched blister systems through extrusion, coextrusion, coating, scoring, printing and slitting. Additional value is created through barrier testing, residual-wall-thickness analysis, sealing-window optimization, machine trials, stability support, recyclability assessment and regulatory documentation. Downstream customers include branded pharmaceutical companies, generic-drug manufacturers, CDMOs, contract packagers and nutraceutical producers. Resin suppliers and blister machinery manufacturers are important enabling participants but belong to different revenue pools from finished OMB film and complete-system suppliers. The highest-value capabilities are proprietary material formulation, validated forming-and-lidding combinations, cleanroom manufacturing, consistency between production batches and the ability to support pharmaceutical customers through qualification and post-approval packaging changes.Segment Insights
PET Material is expected to remain the largest segment over the near term because it has the broadest base of commercially available forming webs and lidding materials. Klöckner Pentaplast supplies mono-PET bottom web, Huhtamaki and PAXXUS provide complementary PET lidding solutions, and Liveo Research, TekniPlex and Hysum Flexibles offer additional PET-based products or complete systems. The platform benefits from optical clarity, thermoformability, established material identification and the availability of push-through and peelable lid formats. PP Material is positioned as the key higher-growth platform because it offers stronger inherent moisture resistance and supports complete forming-and-lidding systems from SÜDPACK, Liveo Research and TekniPlex. The report’s Others segment should cover PE and COC rather than treating them as undefined residual products: PE is represented by recycle-ready thermoformed systems such as AmSky, while COC targets medium-to-high moisture-barrier applications and commands a higher material cost. This three-part segmentation—PET Material, PP Material and Others—therefore remains practical and mutually exclusive for market measurement.Downstream Market Opportunities
Tablets represent the largest addressable application because they are extensively packaged in push-through unit-dose formats and can be accommodated by standardized cavity geometries. Hard capsules form the second major application and require deeper cavities, stable thermoforming and reliable protection against moisture. The Others category covers softgel capsules, lozenges and other solid-dose products where cavity design, chemical compatibility or opening performance differs from standard tablets. Early adoption is most likely in OTC drugs, generic medicines and nutraceutical products with low-to-medium barrier requirements, while moisture-sensitive prescription drugs offer higher-value opportunities for advanced PP and COC structures after stability validation. CDMOs and contract packagers are strategically important because a qualified material platform can be applied across multiple customers, formulations and regional product launches.Regional Insights
Europe is the leading market for product development, qualification and early commercialization, supported by a concentrated pharmaceutical-packaging industry and a regulatory direction that emphasizes packaging minimization, circularity and improved waste management. Germany, Switzerland, the United Kingdom and neighboring converting hubs host many of the current OMB technology and partnership leaders. India offers significant long-term potential through its large generic-drug and export-manufacturing base, but adoption remains sensitive to material cost, existing line performance and the documentation required for primary-packaging changes under CDSCO rules. Export-oriented manufacturers and newly approved products are likely to adopt first. China combines a broad pharmaceutical-packaging supply chain with increasing interest in recyclable materials, and Hysum Flexibles has established a local APET forming-web and lidding platform. However, NMPA associated review and change-management requirements make pharmaceutical validation, registration support and stable domestic supply decisive competitive factors.Report Scope
This report studies the global Pharmaceutical One-Material Blisters (OMB) production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Pharmaceutical One-Material Blisters (OMB) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical One-Material Blisters (OMB) that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Pharmaceutical One-Material Blisters (OMB) total production and demand, 2021-2032, (Tons)
- Global Pharmaceutical One-Material Blisters (OMB) total production value, 2021-2032, (USD Million)
- Global Pharmaceutical One-Material Blisters (OMB) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
- Global Pharmaceutical One-Material Blisters (OMB) consumption by region & country, CAGR, 2021-2032 & (Tons)
- U.S. VS China: Pharmaceutical One-Material Blisters (OMB) domestic production, consumption, key domestic manufacturers and share
- Global Pharmaceutical One-Material Blisters (OMB) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
- Global Pharmaceutical One-Material Blisters (OMB) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
- Global Pharmaceutical One-Material Blisters (OMB) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical One-Material Blisters (OMB) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Pharmaceutical One-Material Blisters (OMB) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Pharmaceutical One-Material Blisters (OMB) Market, Segmentation by Type:
- PET Material
- PP Material
- Others
Global Pharmaceutical One-Material Blisters (OMB) Market, Segmentation by Opening Mechanism:
- Push-Through Blisters
- Peelable Blisters
- Other
Global Pharmaceutical One-Material Blisters (OMB) Market, Segmentation by Forming-Web Thickness:
- Thin-Gauge: ≤249 μm
- Standard-Gauge: 249–359 μm
- Thick-Gauge: ≥359 μm
Global Pharmaceutical One-Material Blisters (OMB) Market, Segmentation by Application:
- Tablets
- Hard Capsules
- Others
Companies Profiled:
- SÜDPACK
- Huhtamaki
- Klöckner Pentaplast
- Amcor
- Liveo Research
- TekniPlex
- Hysum Flexibles
- PAXXUS
Key Questions Answered:
1. How big is the global Pharmaceutical One-Material Blisters (OMB) market?2. What is the demand of the global Pharmaceutical One-Material Blisters (OMB) market?
3. What is the year over year growth of the global Pharmaceutical One-Material Blisters (OMB) market?
4. What is the production and production value of the global Pharmaceutical One-Material Blisters (OMB) market?
5. Who are the key producers in the global Pharmaceutical One-Material Blisters (OMB) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pharmaceutical One-Material Blisters (OMB) Introduction
1.2 World Pharmaceutical One-Material Blisters (OMB) Supply & Forecast
1.2.1 World Pharmaceutical One-Material Blisters (OMB) Production Value (2021 & 2025 & 2032)
1.2.2 World Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.2.3 World Pharmaceutical One-Material Blisters (OMB) Pricing Trends (2021-2032)
1.3 World Pharmaceutical One-Material Blisters (OMB) Production by Region (Based on Production Site)
1.3.1 World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2021-2032)
1.3.2 World Pharmaceutical One-Material Blisters (OMB) Production by Region (2021-2032)
1.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Region (2021-2032)
1.3.4 North America Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.5 Europe Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.6 China Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.7 Japan Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.8 India Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.9 Southeast Asia Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical One-Material Blisters (OMB) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical One-Material Blisters (OMB) Major Market Trends
2 DEMAND SUMMARY
2.1 World Pharmaceutical One-Material Blisters (OMB) Demand (2021-2032)
2.2 World Pharmaceutical One-Material Blisters (OMB) Consumption by Region
2.2.1 World Pharmaceutical One-Material Blisters (OMB) Consumption by Region (2021-2026)
2.2.2 World Pharmaceutical One-Material Blisters (OMB) Consumption Forecast by Region (2027-2032)
2.3 United States Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.4 China Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.5 Europe Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.6 Japan Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.7 South Korea Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.8 ASEAN Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.9 India Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pharmaceutical One-Material Blisters (OMB) Production Value by Manufacturer (2021-2026)
3.2 World Pharmaceutical One-Material Blisters (OMB) Production by Manufacturer (2021-2026)
3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Manufacturer (2021-2026)
3.4 Pharmaceutical One-Material Blisters (OMB) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pharmaceutical One-Material Blisters (OMB) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pharmaceutical One-Material Blisters (OMB) in 2025
3.5.3 Global Concentration Ratios (CR8) for Pharmaceutical One-Material Blisters (OMB) in 2025
3.6 Pharmaceutical One-Material Blisters (OMB) Market: Overall Company Footprint Analysis
3.6.1 Pharmaceutical One-Material Blisters (OMB) Market: Region Footprint
3.6.2 Pharmaceutical One-Material Blisters (OMB) Market: Company Product Type Footprint
3.6.3 Pharmaceutical One-Material Blisters (OMB) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Comparison
4.1.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Comparison
4.2.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Comparison
4.3.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Pharmaceutical One-Material Blisters (OMB) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026)
4.5 China Based Pharmaceutical One-Material Blisters (OMB) Manufacturers and Market Share
4.5.1 China Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value (2021-2026)
4.5.3 China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026)
4.6 Rest of World Based Pharmaceutical One-Material Blisters (OMB) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 PET Material
5.2.2 PP Material
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Type (2021-2032)
5.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Type (2021-2032)
5.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY OPENING MECHANISM
6.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Opening Mechanism: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Opening Mechanism
6.2.1 Push-Through Blisters
6.2.2 Peelable Blisters
6.2.3 Other
6.3 Market Segment by Opening Mechanism
6.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Opening Mechanism (2021-2032)
6.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism (2021-2032)
6.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2021-2032)
7 MARKET ANALYSIS BY FORMING-WEB THICKNESS
7.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Forming-Web Thickness: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Forming-Web Thickness
7.2.1 Thin-Gauge: ≤249 μm
7.2.2 Standard-Gauge: 249–359 μm
7.2.3 Thick-Gauge: ≥359 μm
7.3 Market Segment by Forming-Web Thickness
7.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Forming-Web Thickness (2021-2032)
7.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness (2021-2032)
7.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Tablets
8.2.2 Hard Capsules
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Application (2021-2032)
8.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Application (2021-2032)
8.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 SÜDPACK
9.1.1 SÜDPACK Details
9.1.2 SÜDPACK Major Business
9.1.3 SÜDPACK Pharmaceutical One-Material Blisters (OMB) Product and Services
9.1.4 SÜDPACK Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 SÜDPACK Recent Developments/Updates
9.1.6 SÜDPACK Competitive Strengths & Weaknesses
9.2 Huhtamaki
9.2.1 Huhtamaki Details
9.2.2 Huhtamaki Major Business
9.2.3 Huhtamaki Pharmaceutical One-Material Blisters (OMB) Product and Services
9.2.4 Huhtamaki Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Huhtamaki Recent Developments/Updates
9.2.6 Huhtamaki Competitive Strengths & Weaknesses
9.3 Klöckner Pentaplast
9.3.1 Klöckner Pentaplast Details
9.3.2 Klöckner Pentaplast Major Business
9.3.3 Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Product and Services
9.3.4 Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Klöckner Pentaplast Recent Developments/Updates
9.3.6 Klöckner Pentaplast Competitive Strengths & Weaknesses
9.4 Amcor
9.4.1 Amcor Details
9.4.2 Amcor Major Business
9.4.3 Amcor Pharmaceutical One-Material Blisters (OMB) Product and Services
9.4.4 Amcor Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Amcor Recent Developments/Updates
9.4.6 Amcor Competitive Strengths & Weaknesses
9.5 Liveo Research
9.5.1 Liveo Research Details
9.5.2 Liveo Research Major Business
9.5.3 Liveo Research Pharmaceutical One-Material Blisters (OMB) Product and Services
9.5.4 Liveo Research Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Liveo Research Recent Developments/Updates
9.5.6 Liveo Research Competitive Strengths & Weaknesses
9.6 TekniPlex
9.6.1 TekniPlex Details
9.6.2 TekniPlex Major Business
9.6.3 TekniPlex Pharmaceutical One-Material Blisters (OMB) Product and Services
9.6.4 TekniPlex Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 TekniPlex Recent Developments/Updates
9.6.6 TekniPlex Competitive Strengths & Weaknesses
9.7 Hysum Flexibles
9.7.1 Hysum Flexibles Details
9.7.2 Hysum Flexibles Major Business
9.7.3 Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Product and Services
9.7.4 Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Hysum Flexibles Recent Developments/Updates
9.7.6 Hysum Flexibles Competitive Strengths & Weaknesses
9.8 PAXXUS
9.8.1 PAXXUS Details
9.8.2 PAXXUS Major Business
9.8.3 PAXXUS Pharmaceutical One-Material Blisters (OMB) Product and Services
9.8.4 PAXXUS Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 PAXXUS Recent Developments/Updates
9.8.6 PAXXUS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pharmaceutical One-Material Blisters (OMB) Industry Chain
10.2 Pharmaceutical One-Material Blisters (OMB) Upstream Analysis
10.2.1 Pharmaceutical One-Material Blisters (OMB) Core Raw Materials
10.2.2 Main Manufacturers of Pharmaceutical One-Material Blisters (OMB) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Pharmaceutical One-Material Blisters (OMB) Production Mode
10.6 Pharmaceutical One-Material Blisters (OMB) Procurement Model
10.7 Pharmaceutical One-Material Blisters (OMB) Industry Sales Model and Sales Channels
10.7.1 Pharmaceutical One-Material Blisters (OMB) Sales Model
10.7.2 Pharmaceutical One-Material Blisters (OMB) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Pharmaceutical One-Material Blisters (OMB) Introduction
1.2 World Pharmaceutical One-Material Blisters (OMB) Supply & Forecast
1.2.1 World Pharmaceutical One-Material Blisters (OMB) Production Value (2021 & 2025 & 2032)
1.2.2 World Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.2.3 World Pharmaceutical One-Material Blisters (OMB) Pricing Trends (2021-2032)
1.3 World Pharmaceutical One-Material Blisters (OMB) Production by Region (Based on Production Site)
1.3.1 World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2021-2032)
1.3.2 World Pharmaceutical One-Material Blisters (OMB) Production by Region (2021-2032)
1.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Region (2021-2032)
1.3.4 North America Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.5 Europe Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.6 China Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.7 Japan Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.8 India Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.3.9 Southeast Asia Pharmaceutical One-Material Blisters (OMB) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pharmaceutical One-Material Blisters (OMB) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pharmaceutical One-Material Blisters (OMB) Major Market Trends
2 DEMAND SUMMARY
2.1 World Pharmaceutical One-Material Blisters (OMB) Demand (2021-2032)
2.2 World Pharmaceutical One-Material Blisters (OMB) Consumption by Region
2.2.1 World Pharmaceutical One-Material Blisters (OMB) Consumption by Region (2021-2026)
2.2.2 World Pharmaceutical One-Material Blisters (OMB) Consumption Forecast by Region (2027-2032)
2.3 United States Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.4 China Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.5 Europe Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.6 Japan Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.7 South Korea Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.8 ASEAN Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
2.9 India Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pharmaceutical One-Material Blisters (OMB) Production Value by Manufacturer (2021-2026)
3.2 World Pharmaceutical One-Material Blisters (OMB) Production by Manufacturer (2021-2026)
3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Manufacturer (2021-2026)
3.4 Pharmaceutical One-Material Blisters (OMB) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pharmaceutical One-Material Blisters (OMB) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pharmaceutical One-Material Blisters (OMB) in 2025
3.5.3 Global Concentration Ratios (CR8) for Pharmaceutical One-Material Blisters (OMB) in 2025
3.6 Pharmaceutical One-Material Blisters (OMB) Market: Overall Company Footprint Analysis
3.6.1 Pharmaceutical One-Material Blisters (OMB) Market: Region Footprint
3.6.2 Pharmaceutical One-Material Blisters (OMB) Market: Company Product Type Footprint
3.6.3 Pharmaceutical One-Material Blisters (OMB) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Comparison
4.1.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Comparison
4.2.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Comparison
4.3.1 United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Pharmaceutical One-Material Blisters (OMB) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026)
4.5 China Based Pharmaceutical One-Material Blisters (OMB) Manufacturers and Market Share
4.5.1 China Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value (2021-2026)
4.5.3 China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026)
4.6 Rest of World Based Pharmaceutical One-Material Blisters (OMB) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 PET Material
5.2.2 PP Material
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Type (2021-2032)
5.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Type (2021-2032)
5.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY OPENING MECHANISM
6.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Opening Mechanism: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Opening Mechanism
6.2.1 Push-Through Blisters
6.2.2 Peelable Blisters
6.2.3 Other
6.3 Market Segment by Opening Mechanism
6.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Opening Mechanism (2021-2032)
6.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism (2021-2032)
6.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2021-2032)
7 MARKET ANALYSIS BY FORMING-WEB THICKNESS
7.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Forming-Web Thickness: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Forming-Web Thickness
7.2.1 Thin-Gauge: ≤249 μm
7.2.2 Standard-Gauge: 249–359 μm
7.2.3 Thick-Gauge: ≥359 μm
7.3 Market Segment by Forming-Web Thickness
7.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Forming-Web Thickness (2021-2032)
7.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness (2021-2032)
7.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pharmaceutical One-Material Blisters (OMB) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Tablets
8.2.2 Hard Capsules
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Pharmaceutical One-Material Blisters (OMB) Production by Application (2021-2032)
8.3.2 World Pharmaceutical One-Material Blisters (OMB) Production Value by Application (2021-2032)
8.3.3 World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 SÜDPACK
9.1.1 SÜDPACK Details
9.1.2 SÜDPACK Major Business
9.1.3 SÜDPACK Pharmaceutical One-Material Blisters (OMB) Product and Services
9.1.4 SÜDPACK Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 SÜDPACK Recent Developments/Updates
9.1.6 SÜDPACK Competitive Strengths & Weaknesses
9.2 Huhtamaki
9.2.1 Huhtamaki Details
9.2.2 Huhtamaki Major Business
9.2.3 Huhtamaki Pharmaceutical One-Material Blisters (OMB) Product and Services
9.2.4 Huhtamaki Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Huhtamaki Recent Developments/Updates
9.2.6 Huhtamaki Competitive Strengths & Weaknesses
9.3 Klöckner Pentaplast
9.3.1 Klöckner Pentaplast Details
9.3.2 Klöckner Pentaplast Major Business
9.3.3 Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Product and Services
9.3.4 Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Klöckner Pentaplast Recent Developments/Updates
9.3.6 Klöckner Pentaplast Competitive Strengths & Weaknesses
9.4 Amcor
9.4.1 Amcor Details
9.4.2 Amcor Major Business
9.4.3 Amcor Pharmaceutical One-Material Blisters (OMB) Product and Services
9.4.4 Amcor Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Amcor Recent Developments/Updates
9.4.6 Amcor Competitive Strengths & Weaknesses
9.5 Liveo Research
9.5.1 Liveo Research Details
9.5.2 Liveo Research Major Business
9.5.3 Liveo Research Pharmaceutical One-Material Blisters (OMB) Product and Services
9.5.4 Liveo Research Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Liveo Research Recent Developments/Updates
9.5.6 Liveo Research Competitive Strengths & Weaknesses
9.6 TekniPlex
9.6.1 TekniPlex Details
9.6.2 TekniPlex Major Business
9.6.3 TekniPlex Pharmaceutical One-Material Blisters (OMB) Product and Services
9.6.4 TekniPlex Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 TekniPlex Recent Developments/Updates
9.6.6 TekniPlex Competitive Strengths & Weaknesses
9.7 Hysum Flexibles
9.7.1 Hysum Flexibles Details
9.7.2 Hysum Flexibles Major Business
9.7.3 Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Product and Services
9.7.4 Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Hysum Flexibles Recent Developments/Updates
9.7.6 Hysum Flexibles Competitive Strengths & Weaknesses
9.8 PAXXUS
9.8.1 PAXXUS Details
9.8.2 PAXXUS Major Business
9.8.3 PAXXUS Pharmaceutical One-Material Blisters (OMB) Product and Services
9.8.4 PAXXUS Pharmaceutical One-Material Blisters (OMB) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 PAXXUS Recent Developments/Updates
9.8.6 PAXXUS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pharmaceutical One-Material Blisters (OMB) Industry Chain
10.2 Pharmaceutical One-Material Blisters (OMB) Upstream Analysis
10.2.1 Pharmaceutical One-Material Blisters (OMB) Core Raw Materials
10.2.2 Main Manufacturers of Pharmaceutical One-Material Blisters (OMB) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Pharmaceutical One-Material Blisters (OMB) Production Mode
10.6 Pharmaceutical One-Material Blisters (OMB) Procurement Model
10.7 Pharmaceutical One-Material Blisters (OMB) Industry Sales Model and Sales Channels
10.7.1 Pharmaceutical One-Material Blisters (OMB) Sales Model
10.7.2 Pharmaceutical One-Material Blisters (OMB) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Region (2021-2026)
Table 5. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Region (2027-2032)
Table 6. World Pharmaceutical One-Material Blisters (OMB) Production by Region (2021-2026) & (Tons)
Table 7. World Pharmaceutical One-Material Blisters (OMB) Production by Region (2027-2032) & (Tons)
Table 8. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Region (2021-2026)
Table 9. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Region (2027-2032)
Table 10. World Pharmaceutical One-Material Blisters (OMB) Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Pharmaceutical One-Material Blisters (OMB) Average Price by Region (2027-2032) & (US$/kg)
Table 12. Pharmaceutical One-Material Blisters (OMB) Major Market Trends
Table 13. World Pharmaceutical One-Material Blisters (OMB) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Pharmaceutical One-Material Blisters (OMB) Consumption by Region (2021-2026) & (Tons)
Table 15. World Pharmaceutical One-Material Blisters (OMB) Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Pharmaceutical One-Material Blisters (OMB) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Pharmaceutical One-Material Blisters (OMB) Producers in 2025
Table 18. World Pharmaceutical One-Material Blisters (OMB) Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Pharmaceutical One-Material Blisters (OMB) Producers in 2025
Table 20. World Pharmaceutical One-Material Blisters (OMB) Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Pharmaceutical One-Material Blisters (OMB) Company Evaluation Quadrant
Table 22. World Pharmaceutical One-Material Blisters (OMB) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Pharmaceutical One-Material Blisters (OMB) Production Site of Key Manufacturer
Table 24. Pharmaceutical One-Material Blisters (OMB) Market: Company Product Type Footprint
Table 25. Pharmaceutical One-Material Blisters (OMB) Market: Company Product Application Footprint
Table 26. Pharmaceutical One-Material Blisters (OMB) Competitive Factors
Table 27. Pharmaceutical One-Material Blisters (OMB) New Entrant and Capacity Expansion Plans
Table 28. Pharmaceutical One-Material Blisters (OMB) Mergers & Acquisitions Activity
Table 29. United States VS China Pharmaceutical One-Material Blisters (OMB) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Pharmaceutical One-Material Blisters (OMB) Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Pharmaceutical One-Material Blisters (OMB) Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share (2021-2026)
Table 37. China Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share (2021-2026)
Table 42. Rest of World Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share (2021-2026)
Table 47. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Pharmaceutical One-Material Blisters (OMB) Production by Type (2021-2026) & (Tons)
Table 49. World Pharmaceutical One-Material Blisters (OMB) Production by Type (2027-2032) & (Tons)
Table 50. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism, (USD Million), 2021 & 2025 & 2032
Table 55. World Pharmaceutical One-Material Blisters (OMB) Production by Opening Mechanism (2021-2026) & (Tons)
Table 56. World Pharmaceutical One-Material Blisters (OMB) Production by Opening Mechanism (2027-2032) & (Tons)
Table 57. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism (2021-2026) & (USD Million)
Table 58. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism (2027-2032) & (USD Million)
Table 59. World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2021-2026) & (US$/kg)
Table 60. World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2027-2032) & (US$/kg)
Table 61. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness, (USD Million), 2021 & 2025 & 2032
Table 62. World Pharmaceutical One-Material Blisters (OMB) Production by Forming-Web Thickness (2021-2026) & (Tons)
Table 63. World Pharmaceutical One-Material Blisters (OMB) Production by Forming-Web Thickness (2027-2032) & (Tons)
Table 64. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness (2021-2026) & (USD Million)
Table 65. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness (2027-2032) & (USD Million)
Table 66. World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2021-2026) & (US$/kg)
Table 67. World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2027-2032) & (US$/kg)
Table 68. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Pharmaceutical One-Material Blisters (OMB) Production by Application (2021-2026) & (Tons)
Table 70. World Pharmaceutical One-Material Blisters (OMB) Production by Application (2027-2032) & (Tons)
Table 71. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2027-2032) & (US$/kg)
Table 75. SÜDPACK Basic Information, Manufacturing Base and Competitors
Table 76. SÜDPACK Major Business
Table 77. SÜDPACK Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 78. SÜDPACK Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. SÜDPACK Recent Developments/Updates
Table 80. SÜDPACK Competitive Strengths & Weaknesses
Table 81. Huhtamaki Basic Information, Manufacturing Base and Competitors
Table 82. Huhtamaki Major Business
Table 83. Huhtamaki Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 84. Huhtamaki Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Huhtamaki Recent Developments/Updates
Table 86. Huhtamaki Competitive Strengths & Weaknesses
Table 87. Klöckner Pentaplast Basic Information, Manufacturing Base and Competitors
Table 88. Klöckner Pentaplast Major Business
Table 89. Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 90. Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Klöckner Pentaplast Recent Developments/Updates
Table 92. Klöckner Pentaplast Competitive Strengths & Weaknesses
Table 93. Amcor Basic Information, Manufacturing Base and Competitors
Table 94. Amcor Major Business
Table 95. Amcor Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 96. Amcor Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Amcor Recent Developments/Updates
Table 98. Amcor Competitive Strengths & Weaknesses
Table 99. Liveo Research Basic Information, Manufacturing Base and Competitors
Table 100. Liveo Research Major Business
Table 101. Liveo Research Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 102. Liveo Research Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Liveo Research Recent Developments/Updates
Table 104. Liveo Research Competitive Strengths & Weaknesses
Table 105. TekniPlex Basic Information, Manufacturing Base and Competitors
Table 106. TekniPlex Major Business
Table 107. TekniPlex Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 108. TekniPlex Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. TekniPlex Recent Developments/Updates
Table 110. TekniPlex Competitive Strengths & Weaknesses
Table 111. Hysum Flexibles Basic Information, Manufacturing Base and Competitors
Table 112. Hysum Flexibles Major Business
Table 113. Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 114. Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Hysum Flexibles Recent Developments/Updates
Table 116. Hysum Flexibles Competitive Strengths & Weaknesses
Table 117. PAXXUS Basic Information, Manufacturing Base and Competitors
Table 118. PAXXUS Major Business
Table 119. PAXXUS Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 120. PAXXUS Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. PAXXUS Recent Developments/Updates
Table 122. PAXXUS Competitive Strengths & Weaknesses
Table 123. Global Key Players of Pharmaceutical One-Material Blisters (OMB) Upstream (Raw Materials)
Table 124. Global Pharmaceutical One-Material Blisters (OMB) Typical Customers
Table 125. Pharmaceutical One-Material Blisters (OMB) Typical Distributors
Table 1. World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Pharmaceutical One-Material Blisters (OMB) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Region (2021-2026)
Table 5. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Region (2027-2032)
Table 6. World Pharmaceutical One-Material Blisters (OMB) Production by Region (2021-2026) & (Tons)
Table 7. World Pharmaceutical One-Material Blisters (OMB) Production by Region (2027-2032) & (Tons)
Table 8. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Region (2021-2026)
Table 9. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Region (2027-2032)
Table 10. World Pharmaceutical One-Material Blisters (OMB) Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Pharmaceutical One-Material Blisters (OMB) Average Price by Region (2027-2032) & (US$/kg)
Table 12. Pharmaceutical One-Material Blisters (OMB) Major Market Trends
Table 13. World Pharmaceutical One-Material Blisters (OMB) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Pharmaceutical One-Material Blisters (OMB) Consumption by Region (2021-2026) & (Tons)
Table 15. World Pharmaceutical One-Material Blisters (OMB) Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Pharmaceutical One-Material Blisters (OMB) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Pharmaceutical One-Material Blisters (OMB) Producers in 2025
Table 18. World Pharmaceutical One-Material Blisters (OMB) Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Pharmaceutical One-Material Blisters (OMB) Producers in 2025
Table 20. World Pharmaceutical One-Material Blisters (OMB) Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Pharmaceutical One-Material Blisters (OMB) Company Evaluation Quadrant
Table 22. World Pharmaceutical One-Material Blisters (OMB) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Pharmaceutical One-Material Blisters (OMB) Production Site of Key Manufacturer
Table 24. Pharmaceutical One-Material Blisters (OMB) Market: Company Product Type Footprint
Table 25. Pharmaceutical One-Material Blisters (OMB) Market: Company Product Application Footprint
Table 26. Pharmaceutical One-Material Blisters (OMB) Competitive Factors
Table 27. Pharmaceutical One-Material Blisters (OMB) New Entrant and Capacity Expansion Plans
Table 28. Pharmaceutical One-Material Blisters (OMB) Mergers & Acquisitions Activity
Table 29. United States VS China Pharmaceutical One-Material Blisters (OMB) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Pharmaceutical One-Material Blisters (OMB) Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Pharmaceutical One-Material Blisters (OMB) Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share (2021-2026)
Table 37. China Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share (2021-2026)
Table 42. Rest of World Based Pharmaceutical One-Material Blisters (OMB) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share (2021-2026)
Table 47. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Pharmaceutical One-Material Blisters (OMB) Production by Type (2021-2026) & (Tons)
Table 49. World Pharmaceutical One-Material Blisters (OMB) Production by Type (2027-2032) & (Tons)
Table 50. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism, (USD Million), 2021 & 2025 & 2032
Table 55. World Pharmaceutical One-Material Blisters (OMB) Production by Opening Mechanism (2021-2026) & (Tons)
Table 56. World Pharmaceutical One-Material Blisters (OMB) Production by Opening Mechanism (2027-2032) & (Tons)
Table 57. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism (2021-2026) & (USD Million)
Table 58. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism (2027-2032) & (USD Million)
Table 59. World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2021-2026) & (US$/kg)
Table 60. World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2027-2032) & (US$/kg)
Table 61. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness, (USD Million), 2021 & 2025 & 2032
Table 62. World Pharmaceutical One-Material Blisters (OMB) Production by Forming-Web Thickness (2021-2026) & (Tons)
Table 63. World Pharmaceutical One-Material Blisters (OMB) Production by Forming-Web Thickness (2027-2032) & (Tons)
Table 64. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness (2021-2026) & (USD Million)
Table 65. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness (2027-2032) & (USD Million)
Table 66. World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2021-2026) & (US$/kg)
Table 67. World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2027-2032) & (US$/kg)
Table 68. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Pharmaceutical One-Material Blisters (OMB) Production by Application (2021-2026) & (Tons)
Table 70. World Pharmaceutical One-Material Blisters (OMB) Production by Application (2027-2032) & (Tons)
Table 71. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2027-2032) & (US$/kg)
Table 75. SÜDPACK Basic Information, Manufacturing Base and Competitors
Table 76. SÜDPACK Major Business
Table 77. SÜDPACK Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 78. SÜDPACK Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. SÜDPACK Recent Developments/Updates
Table 80. SÜDPACK Competitive Strengths & Weaknesses
Table 81. Huhtamaki Basic Information, Manufacturing Base and Competitors
Table 82. Huhtamaki Major Business
Table 83. Huhtamaki Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 84. Huhtamaki Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Huhtamaki Recent Developments/Updates
Table 86. Huhtamaki Competitive Strengths & Weaknesses
Table 87. Klöckner Pentaplast Basic Information, Manufacturing Base and Competitors
Table 88. Klöckner Pentaplast Major Business
Table 89. Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 90. Klöckner Pentaplast Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Klöckner Pentaplast Recent Developments/Updates
Table 92. Klöckner Pentaplast Competitive Strengths & Weaknesses
Table 93. Amcor Basic Information, Manufacturing Base and Competitors
Table 94. Amcor Major Business
Table 95. Amcor Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 96. Amcor Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Amcor Recent Developments/Updates
Table 98. Amcor Competitive Strengths & Weaknesses
Table 99. Liveo Research Basic Information, Manufacturing Base and Competitors
Table 100. Liveo Research Major Business
Table 101. Liveo Research Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 102. Liveo Research Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Liveo Research Recent Developments/Updates
Table 104. Liveo Research Competitive Strengths & Weaknesses
Table 105. TekniPlex Basic Information, Manufacturing Base and Competitors
Table 106. TekniPlex Major Business
Table 107. TekniPlex Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 108. TekniPlex Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. TekniPlex Recent Developments/Updates
Table 110. TekniPlex Competitive Strengths & Weaknesses
Table 111. Hysum Flexibles Basic Information, Manufacturing Base and Competitors
Table 112. Hysum Flexibles Major Business
Table 113. Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 114. Hysum Flexibles Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Hysum Flexibles Recent Developments/Updates
Table 116. Hysum Flexibles Competitive Strengths & Weaknesses
Table 117. PAXXUS Basic Information, Manufacturing Base and Competitors
Table 118. PAXXUS Major Business
Table 119. PAXXUS Pharmaceutical One-Material Blisters (OMB) Product and Services
Table 120. PAXXUS Pharmaceutical One-Material Blisters (OMB) Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. PAXXUS Recent Developments/Updates
Table 122. PAXXUS Competitive Strengths & Weaknesses
Table 123. Global Key Players of Pharmaceutical One-Material Blisters (OMB) Upstream (Raw Materials)
Table 124. Global Pharmaceutical One-Material Blisters (OMB) Typical Customers
Table 125. Pharmaceutical One-Material Blisters (OMB) Typical Distributors
LIST OF FIGURES
Figure 1. Pharmaceutical One-Material Blisters (OMB) Picture
Figure 2. World Pharmaceutical One-Material Blisters (OMB) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pharmaceutical One-Material Blisters (OMB) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 5. World Pharmaceutical One-Material Blisters (OMB) Average Price (2021-2032) & (US$/kg)
Figure 6. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Region (2021-2032)
Figure 7. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Region (2021-2032)
Figure 8. North America Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 9. Europe Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 10. China Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 11. Japan Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 12. India Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 13. Southeast Asia Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 14. Pharmaceutical One-Material Blisters (OMB) Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 17. World Pharmaceutical One-Material Blisters (OMB) Consumption Market Share by Region (2021-2032)
Figure 18. United States Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 19. China Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 20. Europe Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 21. Japan Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 22. South Korea Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 23. ASEAN Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 24. India Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 25. Producer Shipments of Pharmaceutical One-Material Blisters (OMB) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical One-Material Blisters (OMB) Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical One-Material Blisters (OMB) Markets in 2025
Figure 28. United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share 2025
Figure 32. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share 2025
Figure 34. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Type in 2025
Figure 36. PET Material
Figure 37. PP Material
Figure 38. Others
Figure 39. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Type (2021-2032)
Figure 40. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Type (2021-2032)
Figure 41. World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2021-2032) & (US$/kg)
Figure 42. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 43. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Opening Mechanism in 2025
Figure 44. Push-Through Blisters
Figure 45. Peelable Blisters
Figure 46. Other
Figure 47. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Opening Mechanism (2021-2032)
Figure 48. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Opening Mechanism (2021-2032)
Figure 49. World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2021-2032) & (US$/kg)
Figure 50. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness, (USD Million), 2021 & 2025 & 2032
Figure 51. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Forming-Web Thickness in 2025
Figure 52. Thin-Gauge: ≤249 μm
Figure 53. Standard-Gauge: 249–359 μm
Figure 54. Thick-Gauge: ≥359 μm
Figure 55. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Forming-Web Thickness (2021-2032)
Figure 56. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Forming-Web Thickness (2021-2032)
Figure 57. World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2021-2032) & (US$/kg)
Figure 58. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Application in 2025
Figure 60. Tablets
Figure 61. Hard Capsules
Figure 62. Others
Figure 63. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Application (2021-2032)
Figure 64. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Application (2021-2032)
Figure 65. World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2021-2032) & (US$/kg)
Figure 66. Pharmaceutical One-Material Blisters (OMB) Industry Chain
Figure 67. Pharmaceutical One-Material Blisters (OMB) Procurement Model
Figure 68. Pharmaceutical One-Material Blisters (OMB) Sales Model
Figure 69. Pharmaceutical One-Material Blisters (OMB) Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Pharmaceutical One-Material Blisters (OMB) Picture
Figure 2. World Pharmaceutical One-Material Blisters (OMB) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pharmaceutical One-Material Blisters (OMB) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 5. World Pharmaceutical One-Material Blisters (OMB) Average Price (2021-2032) & (US$/kg)
Figure 6. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Region (2021-2032)
Figure 7. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Region (2021-2032)
Figure 8. North America Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 9. Europe Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 10. China Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 11. Japan Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 12. India Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 13. Southeast Asia Pharmaceutical One-Material Blisters (OMB) Production (2021-2032) & (Tons)
Figure 14. Pharmaceutical One-Material Blisters (OMB) Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 17. World Pharmaceutical One-Material Blisters (OMB) Consumption Market Share by Region (2021-2032)
Figure 18. United States Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 19. China Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 20. Europe Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 21. Japan Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 22. South Korea Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 23. ASEAN Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 24. India Pharmaceutical One-Material Blisters (OMB) Consumption (2021-2032) & (Tons)
Figure 25. Producer Shipments of Pharmaceutical One-Material Blisters (OMB) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Pharmaceutical One-Material Blisters (OMB) Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Pharmaceutical One-Material Blisters (OMB) Markets in 2025
Figure 28. United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Pharmaceutical One-Material Blisters (OMB) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Pharmaceutical One-Material Blisters (OMB) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share 2025
Figure 32. China Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Pharmaceutical One-Material Blisters (OMB) Production Market Share 2025
Figure 34. World Pharmaceutical One-Material Blisters (OMB) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Type in 2025
Figure 36. PET Material
Figure 37. PP Material
Figure 38. Others
Figure 39. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Type (2021-2032)
Figure 40. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Type (2021-2032)
Figure 41. World Pharmaceutical One-Material Blisters (OMB) Average Price by Type (2021-2032) & (US$/kg)
Figure 42. World Pharmaceutical One-Material Blisters (OMB) Production Value by Opening Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 43. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Opening Mechanism in 2025
Figure 44. Push-Through Blisters
Figure 45. Peelable Blisters
Figure 46. Other
Figure 47. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Opening Mechanism (2021-2032)
Figure 48. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Opening Mechanism (2021-2032)
Figure 49. World Pharmaceutical One-Material Blisters (OMB) Average Price by Opening Mechanism (2021-2032) & (US$/kg)
Figure 50. World Pharmaceutical One-Material Blisters (OMB) Production Value by Forming-Web Thickness, (USD Million), 2021 & 2025 & 2032
Figure 51. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Forming-Web Thickness in 2025
Figure 52. Thin-Gauge: ≤249 μm
Figure 53. Standard-Gauge: 249–359 μm
Figure 54. Thick-Gauge: ≥359 μm
Figure 55. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Forming-Web Thickness (2021-2032)
Figure 56. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Forming-Web Thickness (2021-2032)
Figure 57. World Pharmaceutical One-Material Blisters (OMB) Average Price by Forming-Web Thickness (2021-2032) & (US$/kg)
Figure 58. World Pharmaceutical One-Material Blisters (OMB) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Application in 2025
Figure 60. Tablets
Figure 61. Hard Capsules
Figure 62. Others
Figure 63. World Pharmaceutical One-Material Blisters (OMB) Production Market Share by Application (2021-2032)
Figure 64. World Pharmaceutical One-Material Blisters (OMB) Production Value Market Share by Application (2021-2032)
Figure 65. World Pharmaceutical One-Material Blisters (OMB) Average Price by Application (2021-2032) & (US$/kg)
Figure 66. Pharmaceutical One-Material Blisters (OMB) Industry Chain
Figure 67. Pharmaceutical One-Material Blisters (OMB) Procurement Model
Figure 68. Pharmaceutical One-Material Blisters (OMB) Sales Model
Figure 69. Pharmaceutical One-Material Blisters (OMB) Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
